Chronic hemodynamic effects after radiofrequency catheter ablation of frequent monomorphic ventricular premature beats

被引:81
作者
Sekiguchi, Y
Aonuma, K
Yamauchi, Y
Obayashi, T
Niwa, A
Hachiya, H
Takahashi, A
Nitta, J
Iesaka, Y
Isobe, M
机构
[1] Musashino Red Cross Hosp, Div Cardiovasc, Musashino, Tokyo 1808610, Japan
[2] Tokyo Med & Dent Univ, Dept Cardiovasc Med, Tokyo, Japan
关键词
ablation; ventricular premature beat; left ventricular dimension; B-type natriuretic peptide;
D O I
10.1111/j.1540-8167.2005.40786.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Effects of Ventricular Premature Beats. Introduction: Radiofrequency catheter ablation (RFCA) of severely symptomatic monomorphic ventricular premature beats (VPBs) is reported to be a safe and effective treatment option. However, the chronic hemodynamic effects of these VPBs have not been precisely evaluated. Methods and Results: We sought to investigate chronic effects after decreasing the number of VPBs by RFCA. A total of 47 patients who had no underlying heart disease and frequent monomorphic VPBs, consisting of more than 10,000 beats per day (24,194 +/- 12,516 beats per day), were enrolled. Patients were treated with RFCA and followed up over 6 months as outpatients. Echocardiography and serum B-type natriuretic peptide (BNP) level were repeatedly checked before and after RFCA. In 38 patients, whose VPBs were dramatically decreased to less than 1,000 beats per day by successful RFCA, left ventricular (LV) end-diastolic dimension (LVEDd) and end-systolic dimension (LVESd) measured by echocardiography decreased significantly (LVEDd: 50 +/- 5 to 48 +/- 5 mm, P < 0.01; LVESd: 33 +/- 7 to 30 +/- 6 mm, P < 0.01) in association with improvement of BNP level (39.9 +/- 34.1 to 16.8 +/- 10.3 pg/mL, P = 0.0001). In nine patients, whose VPBs were treated unsuccessfully by RFCA or that recurred, LV dimensions and BNP level did not change during the follow-up period. Conclusion: Significant improvement in LV dimensions and serum BNP level appeared to indicate that RFCA of VPBs ameliorated occult cardiac dysfunction induced by frequent VPBs.
引用
收藏
页码:1057 / 1063
页数:7
相关论文
共 25 条
  • [1] First evidence of premature ventricular complex-induced cardiomyopathy: A potentially reversible cause of heart failure
    Chugh, SS
    Shen, WK
    Luria, DM
    Smith, HC
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (03) : 328 - 329
  • [2] Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting
    Dao, Q
    Krishnaswamy, P
    Kazanegra, R
    Harrison, A
    Amirnovin, R
    Lenert, L
    Clopton, P
    Alberto, J
    Hlavin, P
    Maisel, AS
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 379 - 385
  • [3] The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
    de Lemos, JA
    Morrow, DA
    Bentley, JH
    Omland, T
    Sabatine, MS
    McCabe, CH
    Hall, C
    Cannon, CP
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) : 1014 - 1021
  • [4] Fischer Y, 2001, CLIN CHEM, V47, P591
  • [5] Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia
    Grimm, W
    Menz, V
    Hoffmann, J
    Maisch, B
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2001, 24 (02): : 166 - 171
  • [6] RADIOFREQUENCY ABLATION OF SYMPTOMATIC BUT BENIGN VENTRICULAR ARRHYTHMIAS
    GURSOY, S
    BRUGADA, J
    SOUZA, O
    STEURER, G
    ANDRIES, E
    BRUGADA, P
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (05): : 738 - 741
  • [7] How to diagnose, locate, and ablate coronary cusp ventricular tachycardia
    Hachiya, H
    Aonuma, K
    Yamauchi, Y
    Igawa, M
    Nogami, A
    Iesaka, Y
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2002, 13 (06) : 551 - 556
  • [8] Natriuretic peptides as markers of mild forms of left ventricular dysfunction:: Effects of assays on diagnostic performance of markers
    Hammerer-Lercher, A
    Ludwig, W
    Falkensammer, G
    Müller, S
    Neubauer, E
    Puschendorf, B
    Pachinger, O
    Mair, J
    [J]. CLINICAL CHEMISTRY, 2004, 50 (07) : 1174 - 1183
  • [9] Ventricular tachycardia induced cardiomyopathy: Improvement with radiofrequency ablation
    Jaggarao, NSV
    Nanda, AS
    Daubert, JP
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (04): : 505 - 508
  • [10] Treatment of ventricular tachycardia-induced cardiomyopathy by transcatheter radiofrequency ablation
    Kim, YH
    Goldberger, J
    Kadish, A
    [J]. HEART, 1996, 76 (06) : 550 - 552